Aliceblue ANTInstall and trade smarter everywhere
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Gujarat Kidney & Super Speciality Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.
Price Band
₹114
Per ShareLot Size
128 Shares
Minimum Investment
₹14,592
Issue Size
₹250.8 Cr
Face Value
₹2
Per ShareIPO Type
Book Building
Retail Quota
10%
QIB Quota
75%
NII Quota
15%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
99.1%
Promoter Holding (Post-Issue)
71.45%
Issue Type
Book Building
ISIN
INE0V0W01025
The Company is one of the regional healthcare companies located in the central region of state of Gujarat and operate a chain of midsized multispeciality hospitals, providing integrated healthcare services, with a focus on secondary and tertiary care. The Company, on a consolidated basis, operates seven (07) multispeciality hospitals and four (04) pharmacies operating within its Hospitals, Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), Ashwini Medical Centre (Anand), Ashwini Medical Store (Anand) and Apex Multispeciality & Trauma Center (Bharuch) with a total bed capacity of 490 beds, approved bed capacity of 445 beds and operational bed capacity of 340 beds.
As per the D&B Report, India has witnessed a notable increase in public spending on healthcare infrastructure, reflecting a growing commitment to bolstering the nation's healthcare system. Government health expenditure stood at approximately 1.9% of GDP in 2023-24, an increase from 1.28% in 2018-19. The government aims to raise this to 2.5% by 2025, as outlined in the National Health Policy. This upward trend indicates a prioritization of healthcare investment to address the evolving needs of the population. The public healthcare segment in India, while witnessing positive strides, continues to grapple with the demands of a vast and diverse population, necessitating sustained efforts and investments.
Revenue, profit after tax and total assets across the last 3 reported financial years.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial public offering of 2,20,00,000 equity shares of face value of Rs. 2 each ("Equity Shares") of the company for cash at a price of Rs. 108-Rs. 114 per equity share (including a share premium of Rs. 106-Rs. 112 per equity share) ("Issue Price") aggregating to Rs. 237.6-Rs. 250.80 crores ("Issue"). The issue shall constituted 27.90% of the post-issue paid-up equity share capital of the company. The face value of equity shares is ?2 each. the issue price was 57 times the face value of the equity shares. Bids can be made for a minimum of 128 equity shares and in multiples of 128 equity shares thereafter.
*Subject to approvals and market conditions.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Gujarat Kidney And Super Speciality Limited (the "Issuer" or the "Company") was incorporated under the name and style of `Vihaan Medicare Private Limited', a private limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, in order to align its name with the business carried out by the Company of offering multi-speciality and super-speciality medical services, pursuant to a resolution passed by its Board of Directors in their meeting held on September 04, 2023, and by its Shareholders in an extraordinary general meeting held on September 06, 2023, the name of the Company was changed to `Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad. Further, the Company was converted into a public limited company pursuant to a resolution passed by its Board of Directors in their meeting held on November 02, 2023 and by its Shareholders in an extraordinary general meeting held on November 04, 2023 and consequently the name of the Company was changed to `Gujarat Kidney and Super Speciality Limited' and a fresh certificate of incorporation dated November 24, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.
Wholesaler and Retailer
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.